Lepu Medical Tech Beijing - Asset Resilience Ratio
Lepu Medical Tech Beijing (300003) has an Asset Resilience Ratio of 1.15% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Lepu Medical Tech Beijing balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2024)
This chart shows how Lepu Medical Tech Beijing's Asset Resilience Ratio has changed over time. See what is Lepu Medical Tech Beijing's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Lepu Medical Tech Beijing's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lepu Medical Tech Beijing (300003) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥294.36 Million | 1.15% |
| Total Liquid Assets | CN¥294.36 Million | 1.15% |
Asset Resilience Insights
- Limited Liquidity: Lepu Medical Tech Beijing maintains only 1.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Lepu Medical Tech Beijing Industry Peers by Asset Resilience Ratio
Compare Lepu Medical Tech Beijing's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Lepu Medical Tech Beijing (2008–2024)
The table below shows the annual Asset Resilience Ratio data for Lepu Medical Tech Beijing.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.12% | CN¥274.86 Million ≈ $40.22 Million |
CN¥24.57 Billion ≈ $3.60 Billion |
+0.02pp |
| 2023-12-31 | 1.10% | CN¥275.20 Million ≈ $40.27 Million |
CN¥25.02 Billion ≈ $3.66 Billion |
-0.03pp |
| 2022-12-31 | 1.13% | CN¥277.21 Million ≈ $40.57 Million |
CN¥24.48 Billion ≈ $3.58 Billion |
+0.85pp |
| 2021-12-31 | 0.29% | CN¥59.28 Million ≈ $8.67 Million |
CN¥20.70 Billion ≈ $3.03 Billion |
+0.17pp |
| 2020-12-31 | 0.11% | CN¥20.63 Million ≈ $3.02 Million |
CN¥18.26 Billion ≈ $2.67 Billion |
+0.05pp |
| 2019-12-31 | 0.06% | CN¥10.00 Million ≈ $1.46 Million |
CN¥15.93 Billion ≈ $2.33 Billion |
-1.07pp |
| 2018-12-31 | 1.14% | CN¥171.74 Million ≈ $25.13 Million |
CN¥15.10 Billion ≈ $2.21 Billion |
-0.28pp |
| 2017-12-31 | 1.42% | CN¥181.74 Million ≈ $26.59 Million |
CN¥12.79 Billion ≈ $1.87 Billion |
+1.21pp |
| 2016-12-31 | 0.21% | CN¥20.21 Million ≈ $2.96 Million |
CN¥9.50 Billion ≈ $1.39 Billion |
-0.10pp |
| 2015-12-31 | 0.31% | CN¥24.29 Million ≈ $3.55 Million |
CN¥7.73 Billion ≈ $1.13 Billion |
-58.94pp |
| 2009-12-31 | 59.25% | CN¥1.10 Billion ≈ $160.86 Million |
CN¥1.86 Billion ≈ $271.47 Million |
+59.25pp |
| 2008-12-31 | 0.01% | CN¥35.88K ≈ $5.25K |
CN¥609.24 Million ≈ $89.15 Million |
-- |
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd. develops, manufactures, and distributes medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters, Angiocide peripheral cutting balloons, and PeakSheath disposable artery sheath; and cardiovascular products, such as coronary stents and balloons, catheters, guide … Read more